Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan L Roth

Showing results (181-190 of 450) with videos related to

Pageof 45
Sort By:
Bioorganic & Medicinal Chemistry|December 8, 2004
Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activityDavid Alagille, Ronald M Baldwin, Bryan L Roth, et al.
Beilstein Journal of Organic Chemistry|December 5, 2012
trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT(2) receptor familyAdam Pigott, Stewart Frescas, John D McCorvy, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2005
SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonistHoward Sard, Govindaraj Kumaran, Cynthia Morency, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Functionalization at position 3 of the phenyl ring of the potent mGluR5 noncompetitive antagonists MPEPDavid Alagille, Ronald M Baldwin, Bryan L Roth, et al.
The Journal of Biological Chemistry|December 24, 2008
Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signalingRyan T Strachan, Douglas J Sheffler, Belinda Willard, et al.
Psychopharmacology|March 15, 2005
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?Marilyn A Davies, Beth Ann Compton-Toth, Sandra J Hufeisen, et al.
Journal of Medicinal Chemistry|July 22, 2017
A Simple Representation of Three-Dimensional Molecular StructureSeth D Axen, Xi-Ping Huang, Elena L Cáceres, et al.
Bioorganic & Medicinal Chemistry|January 17, 2012
Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agentsKwakye Peprah, Xue Y Zhu, Suresh V K Eyunni, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidolSeth Y Ablordeppey, Margaret Lyles-Eggleston, Barbara Bricker, et al.
Bioorganic & Medicinal Chemistry|September 25, 2007
Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypesClelia Dallanoce, Marco De Amici, Elisabetta Barocelli, et al.
Pageof 45

Showing results (181-190 of 450) with videos related to

Sort By:
Pageof 45
Bioorganic & Medicinal Chemistry|December 8, 2004
Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activityDavid Alagille, Ronald M Baldwin, Bryan L Roth, et al.
Beilstein Journal of Organic Chemistry|December 5, 2012
trans-2-(2,5-Dimethoxy-4-iodophenyl)cyclopropylamine and trans-2-(2,5-dimethoxy-4-bromophenyl)cyclopropylamine as potent agonists for the 5-HT(2) receptor familyAdam Pigott, Stewart Frescas, John D McCorvy, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2005
SAR of psilocybin analogs: discovery of a selective 5-HT 2C agonistHoward Sard, Govindaraj Kumaran, Cynthia Morency, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
Functionalization at position 3 of the phenyl ring of the potent mGluR5 noncompetitive antagonists MPEPDavid Alagille, Ronald M Baldwin, Bryan L Roth, et al.
The Journal of Biological Chemistry|December 24, 2008
Ribosomal S6 kinase 2 directly phosphorylates the 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor, thereby modulating 5-HT2A signalingRyan T Strachan, Douglas J Sheffler, Belinda Willard, et al.
Psychopharmacology|March 15, 2005
The highly efficacious actions of N-desmethylclozapine at muscarinic receptors are unique and not a common property of either typical or atypical antipsychotic drugs: is M1 agonism a pre-requisite for mimicking clozapine's actions?Marilyn A Davies, Beth Ann Compton-Toth, Sandra J Hufeisen, et al.
Journal of Medicinal Chemistry|July 22, 2017
A Simple Representation of Three-Dimensional Molecular StructureSeth D Axen, Xi-Ping Huang, Elena L Cáceres, et al.
Bioorganic & Medicinal Chemistry|January 17, 2012
Multi-receptor drug design: Haloperidol as a scaffold for the design and synthesis of atypical antipsychotic agentsKwakye Peprah, Xue Y Zhu, Suresh V K Eyunni, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
Evaluation of the eutomer of 4-{3-(4-chlorophenyl)-3-hydroxypyrrolidin-1-yl}-1-(4-fluorophenyl)butan-1-one, {(+)-SYA 09}, a pyrrolidine analog of haloperidolSeth Y Ablordeppey, Margaret Lyles-Eggleston, Barbara Bricker, et al.
Bioorganic & Medicinal Chemistry|September 25, 2007
Novel oxotremorine-related heterocyclic derivatives: Synthesis and in vitro pharmacology at the muscarinic receptor subtypesClelia Dallanoce, Marco De Amici, Elisabetta Barocelli, et al.
Pageof 45